🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK Boots vs LloydsPharmacy — 12 month update Page 6

UK Boots vs LloydsPharmacy — 12 month update

LipidDoc_ATL Mon, Dec 15, 2025 at 8:53 PM 39 replies 1,780 viewsPage 6 of 8
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Feb 10, 2026 at 11:14 AM#26
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

26 24pete_RVA, CarlaRPh_TPA, steph_laguna and 23 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Feb 17, 2026 at 8:52 PM#27
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

27 0Dr.Martinez, mike_mod, SarahChen_PharmD and 24 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Feb 25, 2026 at 6:34 AM#28

Adding the clinical framing, because it changes how the question reads. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Correct me if the detail matters more than I have assumed.

Last edited: Feb 25, 2026 at 12:34 PM
28 1Dr.LipidDallas, alex_tucson, kevin_tulsa and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Mar 4, 2026 at 4:20 PM#29
hans_munich said:
It is worth asking what the claim would look like if it were false.

Same pattern here, and in the same order. The detail I would add is minor and it is already implied above.

29 2Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 26 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Mar 12, 2026 at 2:11 AM#30

Closing the loop on my own question.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

Last edited: Mar 12, 2026 at 7:11 AM
1 24KristenIndy
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register